Kolexia
Houillier Caroline
Neurologie
Hôpital Pitie Salpetriere
Paris, France
211 Activités
98 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Tumeurs du système nerveux central Récidive tumorale locale Glioblastome Lymphome B diffus à grandes cellules Tumeurs du cerveau Lymphome malin non hodgkinien Gliome Lymphome intraoculaire

Industries

SERB
8 collaboration(s)
Dernière en 2023
Biogen
2 collaboration(s)
Dernière en 2022
Janssen
2 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2023

Dernières activités

Analysis of cerebrospinal fluid for the diagnosis of CNS lymphoma: Comparison of the ESCCA/ISCCA protocol and real-world data of the CytHem/LOC French network.
Cytometry. Part B, Clinical cytometry   07 mars 2024
Étude prospective multicentrique du réseau LOC : TEP intérim dans le lymphome primitif du système nerveux central
10e Journées Francophones de Médecine nucléaire - Biarritz   01 mars 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.
Neuro-oncology   16 février 2024
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
LOC-R01: Randomized Phase IB/II Study of Escalating Doses of Lenalidomide and Ibrutinib in Association With R-MPV as a Targeted Induction Treatment for Patients Aged 18 to 60 (up to 65 for Phase II) With a Newly Diagnosed Primary Central Nervous System Lymphoma
Essai Clinique (Institut Curie)   10 janvier 2024
Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review.
Revue neurologique   01 décembre 2023
Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use
65th ASH Annual Meeting Abstracts   02 novembre 2023
P14.08.A PROGNOSTIC VALUE OF CSF IL-10 AT THE 2-MONTH ASSESSMENT AFTER THE START OF INDUCTION CHEMOTHERAPY IN PRIMARY CNS LYMPHOMAS. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
P13.12.A SUBTYPES AND SURVIVAL ANALYSIS ANALYSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA WITH RADIOMICS FEATURES
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023